BAQAX
Price
$11.77
Change
+$0.07 (+0.60%)
Updated
Mar 11 closing price
Net Assets
616.87M
VEMIX
Price
$28.56
Change
+$0.23 (+0.81%)
Updated
Mar 11 closing price
Net Assets
110.13B
Ad is loading...

BAQAX vs VEMIX

Header iconBAQAX vs VEMIX Comparison
Open Charts BAQAX vs VEMIXBanner chart's image
Brown Advisory Emgerg Mkts Select Adv
Price$11.77
Change+$0.07 (+0.60%)
VolumeN/A
Net Assets616.87M
Vanguard Emerging Mkts Stock Idx Instl
Price$28.56
Change+$0.23 (+0.81%)
VolumeN/A
Net Assets110.13B
BAQAX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BAQAX vs. VEMIX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAQAX is a Sell and VEMIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 110B vs. BAQAX (617M). VEMIX pays higher dividends than BAQAX: VEMIX (3.14) vs BAQAX (1.66). BAQAX was incepted earlier than VEMIX: BAQAX (12 years) vs VEMIX (25 years). BAQAX (1.50) is less costly to investors than VEMIX (0.09). BAQAX is a more actively managed with annual turnover of: 70.00 vs. VEMIX (8.00). BAQAX has a lower initial minimum investment than VEMIX: BAQAX (100) vs VEMIX (5000000). BAQAX annual gain was more profitable for investors over the last year : 11.50 vs. VEMIX (9.47). BAQAX return over 5 years is better than : 49.01 vs. VEMIX (43.50).
BAQAXVEMIXBAQAX / VEMIX
Total Expense Ratio1.500.091,667%
Annual Report Gross Expense Ratio1.500.091,667%
Fund Existence12 years25 years-
Gain YTD3.7201.323281%
Front LoadN/AN/A-
Min. Initial Investment10050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets617M110B1%
Annual Yield % from dividends1.663.1453%
Returns for 1 year11.509.47121%
Returns for 3 years18.449.81188%
Returns for 5 years49.0143.50113%
Returns for 10 years36.6835.58103%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONTO123.50-9.32
-7.02%
Onto Innovation
TYRA10.15-0.80
-7.27%
Tyra Biosciences
ARWR15.22-1.75
-10.31%
Arrowhead Pharmaceuticals
CTM1.07-0.15
-12.30%
Castellum
RNAZ1.35-0.22
-14.01%
TransCode Therapeutics Inc